Global, national burden of diseases, injuries among children and adolescents

January 25, 2016

A new report examines global and national trends in the fatal and nonfatal burden of diseases and injuries among children and adolescents in 188 countries based on results from the Global Burden of Disease 2013 study, according to an article published online by JAMA Pediatrics.

Data for estimates in the report by the Global Burden of Disease Pediatrics Collaboration come from vital records registration, verbal autopsy studies, maternal and child death surveillance and other sources.

Among the key findings: The authors explained a variety of limitations to their report, including variations in collecting verbal autopsy data and the quality of the medical certification of causes of death.

"The vast majority of deaths in children and adolescents are preventable. Proven interventions exist to prevent diarrheal and respiratory diseases, neonatal conditions, iron deficiency anemia and road injuries, which result in some of the highest burdens of unnecessary death and disability among children and adolescents. These findings presented herein show that these and other available interventions are underused and point to where more attention is needed. The findings indicate that proven health interventions could save millions of lives. Despite the general decline in mortality, the speed of the decline could still be faster," the article concludes.

(JAMA Pediatr. Published online January 25, 2016. doi:10.1001/jamapediatrics.2015.4276. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see article for additional information, including other authors, author contributions and affiliations, etc.

Editorial: Grand Divergence in Global Child Health

"The article by the Global Burden of Disease (GBD) Pediatrics Collaboration in this issue of JAMA Pediatrics represents an important contribution to the field of global health and provides troubling evidence of the diverging trends in child health and well-being," write Paul H. Wise, M.D., M.P.H., and Gary L. Darmstadt, M.D., M.S., of Stanford University, California, in a related editorial.

"A general child health readership should recognize the value of the GBD initiative, including the article by the GBD Pediatrics Collaboration in this issue, which provides important insights into child health and mortality patterns around the world. However, there is a danger for a general child health readership, the GBD 2013 study's sophisticated methods and beautifully produced, detailed tables will mask the underlying weakness of available data in areas of greatest concern. This risk is less one of misinterpretation than of complacency, a willingness to accept the status quo as adequate. This is not inherently a critique of the GBD 2013 study effort. Rather, it is a critique of global systems that do not provide the GBD 2013 study investigators with the data they require to generate greater confidence in their estimates and analytic findings."

"This confidence will at some level reside in the technical guarantee that all lives are noticed and fundamentally valued, a guarantee that will increasingly prove essential to meeting the urgent health and justice demands of the neediest communities on earth," the editorial concludes.

(JAMA Pediatr. Published online January 25, 2016. doi:10.1001/jamapediatrics.2015.4275. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see article for additional information, including other authors, author contributions and affiliations, etc.
-end-
Media Advisory: To contact corresponding author Theo Vos, Ph.D., M.Sc., call William Heisel at 206-897-2886 or email wheisel@uw.edu. To contact editorial corresponding author Paul H. Wise, M.D., Ph.D., call Erin Digitale 650-724-9175 or email digitale@stanford.edu.

The JAMA Network Journals

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.